No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US Stock MarketDetailed Quotes
BLTE Belite Bio
- 56.210
- +3.170+5.98%
Close Jan 17 16:00 ET
- 56.210
- 0.0000.00%
Post 16:00 ET
1.74BMarket Cap-51.10P/E (TTM)
56.330High53.400Low42.76KVolume54.280Open53.040Pre Close2.36MTurnover0.33%Turnover RatioLossP/E (Static)30.88MShares86.53052wk High15.47P/B727.36MFloat Cap31.00552wk Low--Dividend TTM12.94MShs Float86.530Historical High--Div YieldTTM5.52%Amplitude8.800Historical Low55.182Avg Price1Lot Size
Full Hours
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Belite Bio, Inc (NASDAQ:BLTE): When Will It Breakeven?
Belite Bio Shares Are Trading Higher After the Company Announced LBS-007 Was Granted FDA Fast-track Designation Status for Acute Leukemia.
Express News | Lin Bioscience Receives U.S. FDA Fast Track Designation for Lbs-007
Maxim Group Maintains Belite Bio(BLTE.US) With Buy Rating, Raises Target Price to $110
Analysts Offer Insights on Healthcare Companies: Belite Bio, Inc. ADR (BLTE), Mereo Biopharma Group Plc (MREO) and Fate Therapeutics (FATE)
Belite Bio Is Maintained at Buy by HC Wainwright & Co.
Trending US Stocks
Warren Buffett Portfolio Warren Buffett Portfolio
Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.
Unlock the Full List